96902 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used; Regulators; Modulating activity stimulating, promoting or activating activity
Methods and Systems for Enhancing Protein Production
#2MODULATION OF WNT SIGNALLING IN CORNEAL DISORDERS
#3VECTORS FOR PRODUCTION OF THERAPEUTIC CONSTRUCTS
#4TREATMENT OF CANCER USING AN ANTI-HLA-G/ANTI-CD3 BISPECIFIC ANTIBODY AND A 4-1BB (CD137) AGONIST
#5COMPOSITIONS AND METHODS FOR SELECTIVE GENE REGULATION
#6CELLULAR THERAPEUTICS ENGINEERED WITH SIGNAL MODULATORS AND METHODS OF USE THEREOF
#7Fully-human T cell receptor specific for the 369-377 epitope derived from the HER2/Neu (ERBB2) receptor protein
#8MODIFIED LIVE ATTENUATED FLU VIRUS VACCINES AND USES THEREOF
#9ENGINEERED GENE EFFECTORS, COMPOSITIONS, AND METHODS OF USE THEREOF
#10USE OF CELL MEMBRANE-BOUND SIGNALING FACTORS
#11MANIPULATION OF EIF3 TO MODULATE REPEAT ASSOCIATED NON-ATG (RAN) TRANSLATION
#12INSULIN PROMOTER FOR GENE THERAPY FOR TYPE 2 DIABETES MELLITUS
#13METHOD FOR REPAIRING HAIR CYCLE-RELATED GENES AND METHOD FOR TREATING HAIR CYCLE-RELATED DISEASES USING MIR-520D-5P
#14VGLL4 WITH UCP-1 CIS-REGULATORY ELEMENT AND METHOD OF USE THEREOF
#15CELL CONVERSION
#16CARDIOPROTECTIVE HEART DISEASE THERAPIES
#17BROWN FAT-SELECTIVE ADIPOKINES
#18COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR CELLS
#19DAP12 CONSTRUCTS AND THEIR USE TO ENHANCE DC VACCINES AND IMMUNOTHERAPIES
#20BIRINAPANT POLYMORPH H
#21COMPOSITION AND METHOD FOR DELIVERY OF BMP-2 AMPLIFIER/CO-ACTIVATOR FOR ENHANCEMENT OF OSTEOGENESIS
#22REPROGRAMMED FUNCTIONAL FRAGMENT OF RECOMBINANT ONCOLYTIC VIRUS, COMBINATION, AND APPLICATION THEREOF
#23METHOD FOR MAINTAINING SUPPRESSIVE ACTIVITY OF REGULATORY T CELLS
#24METHOD AND COMPOSITIONS FOR NEURONAL REPROGRAMMING
#25VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
#26CO-EXPRESSION OF CONSTRUCTS AND IMMUNOSTIMULATORY COMPOUNDS
#27RECOMBINANT REVERSE TRANSCRIPTASE WITH IMPROVED PROCESSIVITY
#28Modified RELA Protein for Inducing Interferon Expression and Engineered Immune Cells with Improved Interferon Expression
#29USE OF IRE1ALPHA-XBP1 SIGNALING PATHWAY BIOMARKERS FOR MODULATING IMMUNE RESPONSES
#30ENGINEERED EXTRACELLULAR VESICLES FOR TARGETED DRUG DELIVERY TO MUSCLE
#31CELL
#32LIVER-SPECIFIC WNT SIGNAL ENHANCING MOLECULES AND USES THEREOF
#33MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF
#34NLRP3 Variants & Library Screen for NLRP3 Inhibitors with the Same
#35ATF5 Peptide Variants and Uses Thereof
#36METHODS OF TREATING NEURODEGENERATIVE DISEASES
#37TRANSCRIPTION FACTOR NCGL0581 MUTANT AND USE THEREOF IN L-SERINE DETECTION
#38ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A TRANSCRIPTION FACTOR AND A HEAT SHOCK PROTEIN 90 BINDING DOMAIN
#39NUCLEIC ACID STRUCTURE UTILIZING SNARE
#40LILRB POLYPEPTIDES AND USES THEREOF
#41VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
#42AGENTS AND METHODS FOR TREATING CBP-DEPENDENT CANCERS
#43FRIZZLED-SPECIFIC WNT AGONISTS AND ANTAGONISTS
#44USE OF SEMAPHORIN-4D ANTIBODIES IN COMBINATION WITH AN IMMUNE MODULATING THERAPY TO INHIBIT TUMOR GROWTH AND METASTASIS
#45MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
#46ENGINEERED DNA BINDING PROTEINS
#47SMALL MOLECULE-REGULATED GENE EXPRESSION SYSTEM
#48COMPOSITIONS AND METHODS FOR PRODUCING OREXIN NEUROPEPTIDE USING NANOCAPSULE-BASED DRUG DELIVERY SYSTEM
#49DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#50GENE THERAPY FOR TUBEROUS SCLEROSIS
#51MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH HUMAN DISEASE
#52GENE THERAPY FOR THE TREATMENT OF SEVERE COMBINED IMMUNODEFICIENCY (SCID) RELATED TO RAG1
#53ENHANCER SEQUENCES SPECIFIC FOR CARDIAC FIBROBLASTS AND METHODS OF USE THEREOF
#54Methods and compositions for regenerating tissues
#55RECOMBINANT EOMES RESTORES ANTI-CANCER ACTIVITY OF IMMUNE CELLS
#56IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE
#57Use of cell membrane-bound signaling factors
#58METHOD FOR ANALYSING PLURIPOTENT STEM CELL BIOMARKERS, AND IMPLEMENTATIONS THEREOF
#59NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES
#60Amylin receptor agonists
#61IMMUNOTHERAPY FOR INFLAMMATORY BOWEL DISEASE AND/OR CANCER
#62GENETICALLY MODIFIED GENES AND CELLS, AND METHODS OF USING SAME FOR SILENCING VIRUS GENE EXPRESSION
#63VESTIBULAR SUPPORTING CELL PROMOTERS AND USES THEREOF
#64IMMUNOMODULATORY FUSION PROTEINS AND USES THEREOF
#65PREVENTION AND TREATMENT OF CHEMOTHERAPY-INDUCED NEUROPATHIC PAIN
#66EXPRESSION VECTOR FOR HUMAN NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 (NRF2) AND APPLICATION THEREOF
#67ACTIVE DONOR T CELL STAT6
#68ATF5 peptide variants and uses thereof
#69ANTI-INFLAMMATORY PEPTIDE AND METHOD OF USE THEREOF
#70IMMUNOSTIMULATORY AGENTS IN COMBINATION WITH ANGIOGENESIS INHIBITORS
#71GENETICALLY MODIFIED GENES AND CELLS, AND METHODS OF USING SAME FOR SILENCING VIRUS GENE EXPRESSION
#72MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF CYTOPLASMIC AND CYTOSKELETAL PROTEINS
#73METHODS FOR MODULATING A SRC-1 CONDENSATE
#74METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS
#75CROSSLINKED HELIX DIMER MIMICS OF SOS AND METHODS OF USING SAME
#76RNA-TARGETING COMPOSITIONS AND METHODS FOR TREATING MYOTONIC DYSTROPHY TYPE 1
#77BROWN FAT-SELECTIVE ADIPOKINES
#78WNT SIGNALING AGONIST MOLECULES
#79FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD
#80Cell
#81CONSTITUTIVELY ACTIVE PAYLOADS
#82ENHANCING MITOCHONDRIAL-BASED FLOW AND CATABOLISM OF CHOLESTEROL
#83T CELL RECEPTORS DIRECTED AGAINST BOB1 AND USES THEREOF
#84NOVEL VHL SMALL MOLECULE PROBES
#85ENGINEERED REPRODUCTIVE ISOLATION IN ANIMALS
#86WNT SIGNALING AGONIST MOLECULES
#87MAMMALIAN CELLS FOR PRODUCING A SECRETED PROTEIN
#88VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION
#89Liver-specific Wnt signal enhancing molecules and uses thereof
#90ETV2 AND USES THEREOF
#91ENGINEERED T CELLS FOR EXPRESSION OF CHIMERIC ANITGEN RECEPTORS
#92HOST CELLS OVEREXPRESSING TRANSLATIONAL FACTORS
#93Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
#94RECOMBINANT VARIANTS OF R-SPONDIN PROTEINS AND THEIR USE
#95CHIMERIC MYD88 RECEPTORS FOR REDIRECTING IMMUNOSUPPRESSIVE SIGNALING AND RELATED COMPOSITIONS AND METHODS
#96RECOMBINANT NUCLEIC ACID CONSTRUCT AND USE THEREOF
#97PLANT TRANSACTIVATION INTERACTION MOTIFS AND USES THEREOF
#98Stabilized BCL9 peptides for treatment of aberrant Wnt signaling
#99Cell Lines Secreting Alpha-Synuclein Targeting Antibodies, Progranulin and Prosaposin and a Complex of Both, and GDNF
#100CSRP3 (CYSTEINE AND GLYCINE RICH PROTEIN 3) GENE THERAPY
#101DUAL-VECTOR SYSTEM FOR TREATING HEARING IMPAIRMENT AND USE THEREOF
#102NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS
#103Compositions and Methods for the Treatment of Protein Aggregation Disorders
#104Saposin C pharmaceutical compositions and methods of treating cancer
#105Compositions for Treatment of Vascular Disease
#106Peptide for Inducing Regeneration of Tissue and Use Thereof
#107WNT SIGNALING AGONIST MOLECULES
#108COMPOSITIONS COMPRISING ANNEXIN V AND HPV TUMOR ANTIGEN FUSION POLYPEPTIDES AND METHODS FOR MAKING AND USE
#109Probe and Method for Detecting Membrane-Associated Molecules in Living Cells
#110TREATMENT OF VIRUS-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME
#111REGULATORY NUCLEIC ACID SEQUENCES
#112GENE THERAPY
#113PROTEIN KINASE C MODULATORS
#114A METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS
#115GENE VECTOR CONTROL BY CARDIOMYOCYTE-EXPRESSED MICRORNAS
#116RECOMBINANT THERAPEUTIC INTERVENTIONS FOR CANCER
#117Targeted Translation of RNA with CRISPR-Cas13 to Enhance Protein Synthesis
#118CAR-T CELL THERAPIES WITH ENHANCED EFFICACY
#119Use of MYOG gene as target in preparation of drug for treating cardiomyocyte apoptosis-associated cardiovascular disease
#120GENE THERAPY FOR TREATMENT OF CRX-AUTOSOMAL DOMINANT RETINOPATHIES
#121DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION
#122DAP12 constructs and their use to enhance DC vaccines and immunotherapies
#123MUTANT KLF PROTEIN, AND METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS
#124AAV VECTORS ENCODING NF1 AND USES THEREOF
#125COMPOSITIONS AND METHODS FOR UPREGULATING HLA CLASS I ON TUMOR CELLS
#126GENE THERAPY FOR THE REGENERATION OF AUDITORY HAIR CELLS
#127GENERATION OF ENGINEERED REGULATORY T CELLS
#128Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#129Methods and compositions for reducing the immunogenicity of chimeric notch receptors
#130METHODS AND COMPOSITIONS FOR REDUCING THE IMMUNOGENICITY OF CHIMERIC NOTCH RECEPTORS
#131RNA VIRUS VECTORS CARRYING DAI AND RIPK3
#132RECEPTORS WITH HETEROLOGOUS TRANSMEMBRANE DOMAIN
#133COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#134Fully-human T-cell receptor specific for the 369-377 epitope derived from the Her2/Neu (ERBB2) receptor protein
#135METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS BY REPROGRAMMING SOMATIC CELLS
#136COMPOSITIONS AND METHODS FOR IDENTIFYING REGULATORS OF CELL TYPE FATE SPECIFICATION
#137GENETICALLY ENGINEERED HUMAN FETAL LIVER NICHE AS PLATFORM FOR BIOMANUFACTURING OF HEMATOPOIETIC STEM CELLS
#138METHOD FOR PRODUCING PARVALBUMIN-POSITIVE NERVE CELLS, CELL, AND DIFFERENTIATION INDUCER
#139Methods and compositions for regenerating tissues
#140Modified BCL9 Mimetic Peptides
#141VGLL4 WITH UCP-1 CIS-REGULATORY ELEMENT AND METHOD OF USE THEREOF
#142SCREENING METHOD
#143COMPOSITION COMPRISING MLS-STAT3 FOR PREVENTION OR TREATMENT OF IMMUNE DISEASE
#144Compositions for treatment of vascular disease
#145Neoantigen peptide mimics
#146SYNTHETIC CIRCUIT FOR CELLULAR MULTISTABILITY
#147METHOD FOR INDUCING DIRECT REPROGRAMMING OF URINE CELL INTO RENAL PROGENITOR CELL AND PHARMACEUTICAL COMPOSITION CONTAINING REPROGRAMMED RENAL PROGENITOR CELL
#148IMPROVED THERAPEUTIC METHOD FOR RARE OCULAR DISEASES BY GENE REPLACEMENT
#149TRANSPOSON-BASED MODIFICATIONS OF IMMUNE CELLS
#150STAT3 TRANSCRIPTOME FOR DESIGNING MORE POTENT NK CELLS
#151FACTOR H VECTORS AND USES THEREOF
#152CELLULAR THERAPEUTICS ENGINEERED WITH SIGNAL MODULATORS AND METHODS OF USE THEREOF
#153Agents and methods for treating CBP-dependent cancers
#154Method for treating disease using FOXP3+CD4+ T cells
#155COMPOSITIONS AND METHODS FOR SELECTIVE GENE REGULATION
#156Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#157PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATION
#158IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS
#159Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#160CAGED-DEGRON-BASED MOLECULAR FEEDBACK CIRCUITS AND METHODS OF USING THE SAME
#161SYNTHETIC MOLECULAR FEEDBACK CIRCUITS AND METHODS OF USING THE SAME
#162Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#163FOXM1-DERIVED PEPTIDE, AND VACCINE INCLUDING SAME
#164ISL1 and LHX3 VECTOR
#165AAV vectors encoding NF1 and uses thereof
#166Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#167Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#168Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#169METHODS FOR ACTIVATING T CELLS USING AN INDUCIBLE CHIMERIC POLYPEPTIDE
#170Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responses
#171LIVER-SPECIFIC REGULATORY NUCLEIC ACID SEQUENCES
#172TUNNELING NANOTUBE CELLS AND METHODS OF USE THEREOF FOR DELIVERY OF BIOMOLECULES
#173CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN
#174CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN
#175REGULATORY NUCLEIC ACID SEQUENCES
#176Use of cell membrane-bound signaling factors
#177PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF ISCHEMIC CARDIOVASCULAR DISEASE
#178Method for treating muscular dystrophy by targeting utrophin gene
#179Methods and compositions for regenerating tissues
#180Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
#181Immunostimulatory agents in combination with angiogenesis inhibitors
#182VEGF antagonist formulations suitable for intravitreal administration
#183INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
#184Compositions for treatment of vascular disease
#185NOVEL TRANSCRIPTION ACTIVATOR
#186Use of semaphorin-4D antibodies in combination with an immune modulating therapy to inhibit tumor growth and metastasis
#187Frizzled specific Wnt agonists and antagonists
#188Wnt7 variants capable of activating g-protein coupled receptor (Gpr)124/Reck/frizzled/lipoprotein receptor-related protein (LRP)-mediated Wnt signaling
#189COMPOSITIONS OF STING VARIANTS, COMBINATIONS THEREOF, AND METHODS FOR INDUCING AND ENHANCING AN IMMUNE RESPONSE AGAINST INFECTIONS, DISEASES, AND DISORDERS
#190Artificial transcription factors comprising a sliding domain and uses thereof
#191MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
#192SYSTEM FOR THE ADAPTATION OF CELL-BASED ASSAYS FOR ANALYSIS ON AUTOMATED IMMUNO-ASSAY PLATFORMS
#193Stabilized BCL9 peptides for treatment of aberrant WNT signaling
#194FRET BASED PROTEIN BIOSENSOR FOR DETECTION OF CYCLIC DINUCLEOTIDES
#195Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#196INDUCTIVE REGENERATION OF THE AIRWAY BY TRANSCRIPTIONAL FACTOR MODULATION OF GLANDULAR MYOEPITHELIAL STEM CELLS
#197COMBINATION THERAPIES COMPRISING C/EBP ALPHA SARNA
#198Methods for expressing proteins in axons
#199MANIPULATION OF EIF3 TO MODULATE REPEAT ASSOCIATED NON-ATG (RAN) TRANSLATION
#200METHODS AND COMPOSITIONS TO STIMULATE RETINAL REGENERATION
#201Protein-protein interaction assessed by detecting localized coiled coil subunits
#202Peptide, method and composition for melanin polymerization and hair darkening
#203MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF
#204APJ antibody, fusion protein thereof with Elabela, and pharmaceutical compositions and use thereofus01
#205REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF NEUROLOGICAL DISORDERS
#206Mammalian cells for producing a secreted protein
#207Conjugates of islet neogenesis peptides and analogs, and methods thereof
#208GENERATION OF HUMAN iPS CELLS BY A SYNTHETIC SELF-REPLICATIVE RNA
#209Methods and uses of modulators of anaphase promoting complex (APC) activity for treating cancer
#210NOVEL IMMUNODEFICIENT RAT FOR MODELING HUMAN CANCER
#211Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
#212Plant transactivation interaction motifs and uses thereof
#213COMPOSITIONS AND METHODS DIRECTED TO TREATING LIVER FIBROSIS
#214IN VIVO PRODUCTION OF PROTEINS
#215FLT3L-FC fusion proteins
#216Detection of an autoantibody
#217ATF5 peptide variants and uses thereof
#218METHODS AND MATERIALS FOR TREATING BRAIN INJURIES
#219MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE
#220FLT3L-Fc FUSION PROTEINS AND METHODS OF USE
#221METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS
#222PEPTIDES FOR TREATMENT OF DIABETES
#223Polypeptide exhibiting granulocyte-colony stimulating factor activity
#224VGLL4 with UCP-1 cis-regulatory element and method of use thereof
#225Engineered DNA binding proteins
#226A METHOD FOR GENOME EDITING IN A HOST CELL
#227OPTOGENETIC GENE EXPRESSION SYSTEMS AND METHODS
#228Saposin C pharmaceutical compositions and methods of treating cancer
#229Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment
#230Brown fat-selective adipokines
#231MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES
#232PURIFICATION OF GLUCAGON-LIKE PEPTIDE 1 ANALOGS
#233Method for detecting presence or absence of cancer in a subject using messenger RNA biomarkers
#234PEPTIDE FOR INDUCING REGENERATION OF TISSUE AND USE THEREOF
#235RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci
#236PACAP stabilized peptide
#237COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
#238Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#239Composition for preventing hair loss or promoting hair growth
#240Synthetic truncated norrin protein
#241Cell
#242BICYCLIC PEPTIDE LIGAND STING CONJUGATES AND USES THEREOF
#243Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#244MESSENGER RIBONUCLEIC ACIDS FOR ENHANCING IMMUNE RESPONSES AND METHODS OF USE THEREOF
#245CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN
#246Fully-human t-cell receptor specific for the 369-377 epitope derived from the Her2/neu (ERBB2) receptor protein
#247Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation
#248Methods and compositions for regenerating tissues
#249Gene therapy for ocular disorders
#250Mammalian cells for producing a secreted protein
#251Multiplex Guide RNAS
#252THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOF
#253CONTROLLED MODULATION OF AMINO ACID SIDE CHAIN LENGTH OF PEPTIDE ANTIGENS
#254Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#255Engineered CRISPR-Cas9 Nucleases
#256Peptide compound
#257CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN
#258VEGF antagonist formulations suitable for intravitreal administration
#259PANCREATIC CANCER TARGETS AND USES THEREOF
#260Screening method
#261Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#262Peptides for treatment of diabetes
#263Gene therapy for tuberous sclerosis
#264Genetically modified genes and cells, and methods of using same for silencing virus gene expression
#265GILZ formulations for wound healing
#266Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides
#267VEGF antagonist formulations suitable for intravitreal administration
#268Immunomodulatory fusion proteins and uses thereof
#269Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#270Methods for treatment of erectile dysfunction with sonic hedgehog compounds
#271HLA Class II Deficient Cells, HLA Class I Deficient Cells Capable of Expressing HLA Class II Proteins, and Uses Thereof
#272Skeletal muscle cells and method for inducing same
#273Generation of human iPS cells by a synthetic self-replicative RNA
#274Plant transactivation interaction motifs and uses thereof
#275Viral vector constructs for expression of genetic adjuvants activating the STING pathway
#276Composition and method for delivery of BMP-2 amplifler/co-activator for enhancement of osteogenesis
#277In vivo production of proteins
#278Thiol-yne based peptide stapling and uses thereof
#279Saposin C pharmaceutical compositions and methods of treating cancer
#280Agents and methods for treating CBP-dependent cancers
#281Production cell line enhancers
#282Cell-based assay for determining mTOR activity
#283Mesenchymal stem cells expressing anti-inflammatory cytokines and methods of use
#284Use of semaphorin-4D inhibitory molecules with an immune modulating therapy to inhibit tumor growth and metastases
#285Compositions and Methods for Inhibiting Tumor Cells by Inhibiting the Transcription Factor ATF5
#286MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
#287Treatment for glaucoma and other eye diseases
#288Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema
#289RNA virus vectors carrying DAI and RIPK3
#290ATF5 peptide variants and uses thereof
#291Immunostimulating peptides
#292Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#293Synthetic MBNL proteins for treatment of repeat expansion disease
#294Modulation of BCL11A for treatment of hemoglobinopathies
#295Retinal capillary regeneration with synthetic norrin protein
#296PLIF MULTIMERIC PEPTIDES AND USES THEREOF
#297MANIPULATION OF EIF3 TO MODULATE REPEAT ASSOCIATED NON-ATG (RAN) TRANSLATION
#298Agonist agents of CD47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death
#299Conjugates of islet neogenesis peptides and analogs, and methods thereof
#300Purification of glucagon-like peptide 1 analogs